Structure-activity relationship and cytotoxicity of the new thiosemicarbazide derivatives and their Cu(II) complexes against prostate and melanoma cancer cells.
Antimicrobial and anticancer activity
Cu(II) complex
FTIR spectroscopy
Thiosemicarbazide derivative
X-ray analysis
Journal
Archives of biochemistry and biophysics
ISSN: 1096-0384
Titre abrégé: Arch Biochem Biophys
Pays: United States
ID NLM: 0372430
Informations de publication
Date de publication:
07 Mar 2024
07 Mar 2024
Historique:
received:
22
12
2023
revised:
15
02
2024
accepted:
06
03
2024
medline:
10
3
2024
pubmed:
10
3
2024
entrez:
9
3
2024
Statut:
aheadofprint
Résumé
In this study, eighteen new ligands (B1-B18) containing a thiosemicarbazide core were synthesized and characterized in terms of physicochemical properties, molecular docking and in vitro biological activity. The structures of eleven ligands were investigated using X-Ray diffraction and Hirschfeld Surface analysis. To study the structure-activity relationship, the organic ligands contained pyridin-2-ylmethyl, pyridin-3-ylmethyl or pyridin-4-ylmethyl moieties and various substituents. Their pharmakokinetic profiles and molecular docking results suggest high potential as new drug candidates. The complexing ability of the selected organic ligands was also evaluated, yielding five new Cu(II) complexes (Cu(B1)Cl
Identifiants
pubmed: 38460659
pii: S0003-9861(24)00074-2
doi: 10.1016/j.abb.2024.109955
pii:
doi:
Types de publication
Journal Article
Langues
eng
Sous-ensembles de citation
IM
Pagination
109955Informations de copyright
Copyright © 2024. Published by Elsevier Inc.